Thomas M. Mcausland
Guelph, ON N1G2W1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Oncolytic Newcastle-disease-virus-mediated CD47 blockade in preclinical melanoma and pancreatic cancer models.
Journal: Molecular therapy. Oncology
Published: August 10, 2025
Recombinant Newcastle disease viruses expressing immunological checkpoint inhibitors induce a pro-inflammatory state and enhance tumor-specific immune responses in two murine models of cancer.
Journal: Frontiers in microbiology
Published: October 21, 2023
A promoterless AAV6.2FF-based lung gene editing platform for the correction of surfactant protein B deficiency.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 17, 2023
Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: February 12, 2022
Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy.
Journal: Molecular therapy. Methods & clinical development
Published: March 02, 2021
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models.
Journal: Molecular therapy oncolytics
Published: January 08, 2021
Tumour vasculature: Friend or foe of oncolytic viruses?
Journal: Cytokine & growth factor reviews
Published: June 16, 2020
Interference chromatography: a novel approach to optimizing chromatographic selectivity and separation performance for virus purification.
Journal: BMC biotechnology
Published: August 30, 2019
Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies.
Journal: Molecular therapy. Methods & clinical development
Published: November 18, 2018
Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer.
Journal: Molecular therapy. Methods & clinical development
Published: August 14, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026